
California physician practice to pay $6.73M for unnecessary procedures; disrupted sleep cycles linked to dementia risk; HHS launches Moms.gov – Morning Medical Update
Key Takeaways
- Federal prosecutors alleged a Huntington Park vascular center billed Medicare for repeated, clinically unjustified dialysis access and PAD interventions, supported by falsified records, culminating in a $6.73M settlement.
- Preclinical work links chronic circadian disruption to stress-primed microglia, impaired debris clearance, and heightened amyloid-associated neuroinflammation, suggesting a mechanistic bridge between shift work and dementia risk.
The top news stories in medicine today.
California physician practice to pay $6.73M over medically unnecessary procedures
Feliciano Serrano, M.D., allegedly told patients their legs would need amputation to coerce them into procedures they did not need.
A California vascular practice and physician have agreed to pay more than $6.73 million to resolve
One patient received approximately 42 stents in a dialysis segment between 2016 and 2023, including during a period when Serrano told the patient he did not need dialysis. Another received approximately 16 atherectomies in his legs between 2019 and 2023. Prosecutors also alleged Serrano told patients their legs would require amputation if they declined procedures, when little or no such risk existed. The settlement was triggered by a whistleblower lawsuit filed by Lincoln Analytics Inc., which will receive approximately $976,000 from the recovery. The claims resolved are allegations only and no determination of liability has been made.
Disrupted sleep cycles may trigger brain inflammation linked to dementia
Texas A&M scientists are testing whether a stem cell-derived therapy can prevent or reverse the microglial changes associated with Alzheimer's risk.
Researchers at
The finding builds on earlier published work and is now the subject of a new $1.325 million seedling grant from Texas A&M's Dementia & Alzheimer's Research Initiative. Funded researcher Karienn Souza is testing whether an extracellular vesicle therapy, which uses nano-sized particles derived from stem cells to send anti-inflammatory signals to microglia, can prevent or reverse those changes in an animal model. "Only 3% of Alzheimer's risk is genetic, and the rest is environmental," Souza said. Alzheimer's disease and other dementias currently affect approximately 55 million people worldwide, a number expected to nearly triple by 2050.
HHS launches Moms.gov, a federal resource for new and expecting mothers
The site, which went live on Mother's Day, includes guidance on pregnancy, nutrition, breastfeeding, mental health and available federal programs.
The Department of Health and Human Services (HHS) launched
"





